ALB and plasma cell myeloma: There were no significant differences between MRD-negative and MRD-positive patients in terms of gender, myeloma type, DS stage, ISS stage, BMPC ≥ 60%, LDH, calcium, albumin, renal function, hemoglobulin, cytogenetics, extramedullary diseases, circulating plasma cell ≥ 0.105.